Aspira Women's Health Inc.

AWHL · OTCM

CIK 926617fmd_016JBRKAA6GM370EMEDXXXVAGAManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2010 to Jun 30, 2026, 65 periods

Ratios computed from the standardized statements. Select a value to open its proof.